SYBX
HEALTHCARESynlogic Inc
—PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving SYBX Today?
No stock-specific AI insight has been generated for SYBX yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$7M
P/E Ratio—
EPS$-0.08
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding11.7M
SYBX News
1 articlePrice Data
Open—
Previous Close—
Day High—
Day Low—
52 Week High$1.96
52 Week Low$0.54
Fundamentals
Market Cap$7M
P/E Ratio—
EPS$-0.08
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding11.7M
About Synlogic Inc
Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic drugs to treat cancer, inflammatory, and metabolic diseases in the United States. The company is headquartered in Cambridge, Massachusetts.
Listed October 1, 2015
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—